A PHASE I STUDY OF INTRAVENOUS OR INTRAPERITONEAL PLATINUM BASED CHEMOTHERAPY IN COMBINATION WITH VELIPARIB AND BEVACIZUMAB IN NEWLY DIAGNOSED OVARIAN, PRIMARY PERITONEAL AND FALLOPIAN TUBE CANCER

BACKGROUND: Improvements in disease free survival for epithelial ovarian, peritoneal or fallopian tube cancer (EOC) will only come with improved primary therapy. Incorporation of poly-ADP-ribose inhibitors (PARPi) in the frontline setting may represent one strategy. This study sought to determine th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gynecol Oncol
Main Authors: Moore, Kathleen N., Miller, Austin, Bell-McGuinn, Katherine M, Schilder, Russell J, Walker, Joan L, O’Cearbhaill, Roisin E, Guntupalli, Saketh R, Armstrong, Deborah K., Hagemann, Andrea R., Gray, Heidi J., Duska, Linda R., Mathews, Cara A, Chen, Alice, O’Malley, David, Gordon, Sarah, Fracasso, Paula M, Aghajanian, Carol
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7048389/
https://ncbi.nlm.nih.gov/pubmed/31708167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2019.10.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados